Pregabalin vs Gabapentin for Neuropathic Pain

Comparison of Key Properties

Pregabalin has linear pharmacokinetics, allowing for more predictable dosing, and may provide analgesia more quickly than gabapentin, with an initial dosage of 150 mg/day found efficacious in some trials, according to the Mayo Clinic Proceedings 1, 2
The American College of Physicians recommends pregabalin for its simpler dosing regimen, typically twice daily, compared to gabapentin, which is dosed three times daily 2
Pregabalin requires less time to titrate to full therapeutic dosage and has a superior adverse event profile in comparative studies, as reported by Diabetes/Metabolism Research and Reviews 2, 3

The recommended starting dose for pregabalin is 50 mg three times daily or 75 mg twice daily, with an increase to 300 mg/day after 3-7 days, as suggested by the Mayo Clinic Proceedings 1, 2
The maximum dose for pregabalin is 600 mg/day, and higher dosages are not consistently more effective and are associated with greater adverse effects, according to the Mayo Clinic Proceedings 1, 2
The American Geriatrics Society recommends considering lower starting dosages and slower titration in geriatric patients, with starting doses of 25-50 mg/day for pregabalin and 100-200 mg/day for gabapentin 4

Both medications require dose reduction in patients with impaired renal function, as reported by the Mayo Clinic Proceedings 1, 2
Pregabalin and gabapentin may cause edema and should be used with caution in patients with fluid retention issues, according to Diabetes/Metabolism Research and Reviews 3

Both medications have shown efficacy in various neuropathic pain conditions, with pregabalin appearing to have similar efficacy to gabapentin but with pharmacokinetic advantages, as reported by the Mayo Clinic Proceedings 1, 2
Pregabalin was preferred over amitriptyline due to its superior adverse event profile despite similar efficacy, according to Diabetes/Metabolism Research and Reviews 3

Combination therapy with pregabalin and other agents may be considered if monotherapy provides inadequate pain relief, as suggested by Diabetes/Metabolism Research and Reviews and the Mayo Clinic Proceedings 3, 5
The combination of nortriptyline and gabapentin has shown superior efficacy compared to either medication alone, according to Diabetes/Metabolism Research and Reviews and the Mayo Clinic Proceedings 3, 5

Rapid titration increases the risk of adverse effects, particularly in elderly patients, and an adequate trial requires sufficient time, as reported by the Journal of the American Geriatrics Society and the Mayo Clinic Proceedings 1, 4
Pregabalin is a Schedule V controlled substance in the United States, and common side effects include somnolence, dizziness, and mental clouding, which can be particularly problematic in older patients, according to the Mayo Clinic Proceedings and the Journal of the American Geriatrics Society 2, 4